X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (12) 12
female (12) 12
humans (12) 12
index medicus (12) 12
male (12) 12
middle aged (11) 11
adult (9) 9
oncology (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
aged, 80 and over (6) 6
colorectal neoplasms - genetics (6) 6
genotype (6) 6
polymorphism, genetic (6) 6
prognosis (6) 6
chemotherapy (5) 5
colorectal neoplasms - drug therapy (5) 5
stomach neoplasms - genetics (5) 5
camptothecin - administration & dosage (4) 4
camptothecin - analogs & derivatives (4) 4
colorectal cancer (4) 4
stomach neoplasms - drug therapy (4) 4
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized (3) 3
case-control studies (3) 3
cetuximab (3) 3
colorectal neoplasms - pathology (3) 3
disease-free survival (3) 3
fluorouracil - administration & dosage (3) 3
messenger-rna levels (3) 3
pharmacogenetics (3) 3
polymorphism (3) 3
prospective studies (3) 3
research (3) 3
risk factors (3) 3
single nucleotide polymorphism (3) 3
survival analysis (3) 3
thymidylate synthase - genetics (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
cancer (2) 2
carcinoma (2) 2
cells (2) 2
chinese population (2) 2
colon-cancer (2) 2
colorectal neoplasms - metabolism (2) 2
drug therapy (2) 2
excision-repair (2) 2
functional-analysis (2) 2
glutathione-s-transferase (2) 2
haplotypes (2) 2
infusions, intravenous (2) 2
insulin-like growth factor i - metabolism (2) 2
leucovorin - administration & dosage (2) 2
metastasis (2) 2
metastatic colorectal-cancer (2) 2
methylenetetrahydrofolate reductase (2) 2
methylenetetrahydrofolate reductase - genetics (2) 2
neoplasm metastasis (2) 2
organoplatinum compounds - administration & dosage (2) 2
organoplatinum compounds - adverse effects (2) 2
oxaliplatin (2) 2
plus irinotecan (2) 2
polymorphisms (2) 2
recurrence (2) 2
retrospective studies (2) 2
stomach cancer (2) 2
stomach neoplasms - pathology (2) 2
survival (2) 2
survival rate (2) 2
thymidylate synthase (2) 2
thymidylate-synthase gene (2) 2
xpd polymorphisms (2) 2
1st-line treatment (1) 1
2 subtypes (1) 1
5' untranslated regions (1) 1
5,10-methylenetetrahydrofolate reductase (1) 1
5-fluorouracil (1) 1
abdominal surgery (1) 1
adenocarcinoma, mucinous - mortality (1) 1
adenocarcinoma, mucinous - secondary (1) 1
adenocarcinoma, mucinous - surgery (1) 1
advanced colorectal-cancer (1) 1
advanced esophagogastric cancer (1) 1
age factors (1) 1
aged patients (1) 1
analysis of variance (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
apoptosis (1) 1
arg399gln polymorphism (1) 1
association (1) 1
bioavailability (1) 1
biomarkers, tumor - genetics (1) 1
biweekly oxaliplatin (1) 1
bladder-cancer (1) 1
c-myc (1) 1
camptothecin - adverse effects (1) 1
cancer patients (1) 1
cancer research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 04/2007, Volume 25, Issue 10, pp. 1247 - 1254
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 9, pp. 1427 - 1434
Purpose Regulation of epidermal growth factor receptor (EGFR) signaling pathways may play a relevant role in determining the activity of cetuximab therapy in... 
DEPENDENT CELLULAR CYTOTOXICITY | LUNG-CANCER | CELLS | FUNCTIONAL POLYMORPHISM | FACTOR RECEPTOR EGFR | ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | DINUCLEOTIDE REPEAT POLYMORPHISM | INTRON-1 POLYMORPHISM | MODULATION | GENE-TRANSCRIPTION | Haplotypes | Leucovorin - administration & dosage | Receptor, Epidermal Growth Factor - genetics | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Prospective Studies | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Cetuximab | Gene Expression Regulation, Neoplastic - genetics | Camptothecin - analogs & derivatives | Drug Administration Schedule | Proportional Hazards Models | Signal Transduction - genetics | Genetic Markers | Disease Progression | Polymorphism, Genetic | Disease-Free Survival | Analysis of Variance | Signal Transduction - drug effects | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Biomarkers, Tumor - genetics | Infusions, Intravenous | Colorectal Neoplasms - pathology | Salvage Therapy - methods | Index Medicus
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2013, Volume 16, Issue 3, pp. 411 - 419
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 10/2010, Volume 127, Issue 8, pp. 1941 - 1947
Journal Article
The Oncologist, ISSN 1083-7159, 01/2011, Volume 16, Issue 1, pp. 53 - 60
Journal Article
Cancer, ISSN 0008-543X, 03/2006, Volume 106, Issue 5, pp. 1007 - 1016
BACKGROUND. In the Current Phase II Study, the authors evaluated the association between genomic polymorphic variants in uridine diphosphate glucuronosyl... 
Gastrointestinal toxicity | Raltitrexed | Irinotecan | Colorectal carcinoma | UGt1A1 promoter polymorphism | 1ST-LINE TREATMENT | irinotecan | THYMIDYLATE SYNTHASE | FLUOROURACIL FAILURE | RANDOMIZED-TRIAL | PHASE-II | gastrointestinal toxicity | OXALIPLATIN | colorectal carcinoma | raltitrexed | METASTATIC COLORECTAL-CANCER | GENE | ONCOLOGY | PHARMACOGENETICS | CONTINUOUS-INFUSION | UGT1A1 promoter polymorphism | Predictive Value of Tests | Thiophenes - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Carbon-Nitrogen Ligases - genetics | Glucuronosyltransferase - genetics | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Carcinoma - drug therapy | Camptothecin - adverse effects | Promoter Regions, Genetic | Carbon-Nitrogen Ligases - metabolism | Thymidylate Synthase - metabolism | Genotype | Thymidylate Synthase - genetics | Polymorphism, Genetic | Vomiting - chemically induced | Glucuronosyltransferase - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - adverse effects | Carcinoma - genetics | Aged | Infusions, Intravenous | Promoters (Genetics) | Research | Drug therapy | Gastrointestinal diseases | Risk factors | Colorectal cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Pharmacogenomics, ISSN 1462-2416, 09/2010, Volume 11, Issue 9, pp. 1247 - 1256
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.